Bavarian Nordic delivers strategic smallpox vaccine to US
This article was originally published in Scrip
Danish biotech company Bavarian Nordic has delivered the first batch of one million doses of its smallpox vaccine Imvamune to be stored in the US Strategic National Stockpile as a resource for fighting bioterrorism. The FDA authorised the delivery, which was the company's first major product sale in the US, on 17 March.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.